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Fibroblasts interact with the extracellular matrix through 
cell-surface receptors belonging to the integrin family. In 
this report, we present evidence that cultured normal human 
fibroblasts express the integrin a4PI and that this receptor 
facilitates fibroblast attachment to fibronectin. Fluorescence-
activated cell sorter analysis and immunoprecipitation with 
monoclonal antibodies demonstrated that normal dermal fi-
broblasts express the a 4 -subunit on the cell surface, primarily 
in association with the PI -subunit. Cell-attachment assays 
demonstrated that normal human fibroblasts can attach to the 
40-kDa fibronectin fragment containing the type III con-
necting segment domain recognized by a4PI' Adhesion to 
this fragment was inhibited by anti-a4 antibody. Further-
more, our results indicate that a4PI collaborates with another 
I nteractions between a cell and the extracellular matrix are critical for guiding embryogenesis, morphogenesis, and wound repair. The progress of wound repair requires the proliferation and migration of epidermal keratinocytes at the surface of the wound bed and of fibroblasts within the dermis 
around the wound. Like other cell types, dermal fibroblasts interact 
with the matrix through cell-surface receptors for specific matrix 
molecules. Many of these receptors belong to the integrin family 
[1 - 4]. An integrin is a dimer composed of an a-subunit and a p-sub-
unit locked tightly together. The bulk of each subunit is located on 
the cell surface, where the integrin binds to its ligands, but each 
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Abbreviations: 
CHAPS: 3-[ (3-cholamidopropyl )-dimethylammonio )-1-propanesul-
fonate 
EDTA: ethylenediaminetetraacetic acid 
FACS: fluorescence-activated cell sorter 
IlICS: type III connecting segment 
Ig: immunoglobulin 
IP: immunoprecipitation 
LSB: Living Skin Bank fibroblast culture 
PBS: phosphate-buffered salinc 
RGD: arg-gly-asp 
SDS-PAGE: sodium dodecyl sulfate-polyactylamide gel electro-
phoresis 
TBS: Tris-bulfercd sa line 
Tris: Tris(hydroxymethyl)aminomethanc 
VCAM: vascular cell adhesion molecule-l 
fibronectin receptor, asPI, during fibroblast attachment to 
full-length fibronectin. The region of fibronectin recognized 
by asPI contains the amino acid sequence arg - gly - asp 
(RGD). A short synthetic RGD peptide, or the 120-kDa 
fibronectin fragment containing the RGD sequence, only 
partially inhibited attachment to full-length fibronectin , 
suggesting that fibroblasts utilize more than the RGD recog-
nition sequence for binding to fibronectin. Accordingly, 
RGD peptide combined with anti-a4 antibody produced 
more potent inhibition of cell attachment than either reagent 
alone. These observations show for the first time that func-
tional a4PI fibronectin receptor is not restricted to lymphoid 
cells and transformed cells.] Invest DermatoI100:323-328, 
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subunit also spans the plasma membrane and ends inside the cell 
with a short cytoplasmic domain. Current reports have identified 14 
different a-subunits and eight p-subunits [4] . The PI-subunit can 
form complexes with at least eight different a-subunits. These dif-
ferent PI -integrins can be distinguished functionally because they 
bind to different sets of ligands. For example, asPl binds only to 
fibronectin [5]; aJJI binds to fibronectin, collagen, laminin, and 
epiligrin [5,6]. 
Fibronectin i~ a~ abund.ant extracellular matrix protein that 
occurs naturally III dIfferent ISO forms [7,8]. Fibronectin can bind to a 
number of other proteins, such as proteoglycans, fibrinogen, and 
collagen [7,8]. In the dermis, fibronectin is found deposited along 
collagen fibrils [9]. Fibronectin also serves as a substrate for cell 
adhesion, and the interaction between cells and fibronectin has been 
extensively studied. 
Cells can attach to two different regions of the fibronectin mole-
cule [8,10]. The first region, referred to as the central cell-binding 
domain, is found in all fibronectin isoforms and contains the amino 
acid sequence arg - gly - asp (RGD), which serves as the recognition 
sequence for cell attachment to this domain [7] . Short, synthetic 
peptides containing the sequence RGD can inhibit cell attachment 
to fibronectin . Integrin asP, and other integrins bind to the RGD 
site of fibronectin [10]. 
The second cell-attachment region , referred to as the type III 
connecting segment [(IIICS), also know as V], is found only in 
certain isoforms of fibronectin. It is included or excluded through 
alternative splicing of the single mRNA transcript for fibronectin 
[7,8]. This region contains two different amino acid sequences, 
referred to as CS-1 and CS-S, which appear to promote cell attach-
ment. Integrin ail, can bind to IIICS at either of these two sites, but 
it appears to have a higher affinity for the CS-l amino acid sequence 
[11-13]. Although a wide variety of cell types adhere to the RGD 
site of fibronectin, relatively few cell types adhere to IlICS. Cells 
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from the peripheral nervous system, melanoma cells, and lymphoid 
cell s are currently the only cell types proved to adhere to the IllCS 
domain [8]. The receptor responsible for that adhesion has been 
identified as a (X4Pt in lymphocytes [11,12,14] and in melanoma 
cells [13,15]. 
This report presents evidence that another cell type, the normal 
human dermal fibroblast, expresses (X4Pt and that this receptor func-
tions during fibroblast attachment to the IIICS region of fibronec-
tin. There are two compelling reasons for examining the expression 
and function of (X4Pt in normal fibroblasts. First, the current data on 
the distribution of this receptor are contradictory. Integrin (X4Pt 
appears to be expressed by some normal fibroblasts but not by others. 
It is expressed at low levels in human neonatal foreskin fibrob lasts 
[11] and in two normal human fibroblast strains, FS4 and GM3349 
[16], but it is not expressed in another normal human fibroblast, 
WI-38 [17]. Second, the function of (X4Pt in normal fibroblasts has 
not been studied. Indeed, a survey of the literature reveals that the 
function of (X4Pt as a fibronectin receptor has not been investigated 
in any normally adherent cell type. Functional studies of (X4Pt as a 
fibronectin receptor have so far been restricted to hematopoietic 
cells and transformed cells. 
MATERIALS AND METHODS 
Materials Vitronectin, fibron ectin, 40- and 120-kDa fibronectin 
fragments, and the synthetic peptides GRGDSP and GRGESP came 
from Telios Pharmaceuticals (San Diego, CA). Fibrinogen was ob-
tained from the N ew York Blood Center (New York, NY) . Protein 
concentration was measured by the bicinchoninic acid protein assay 
(Pierce Chemical Co., Rockford , IL) . 
Cell Culture Cultures of normal human fibroblasts isolated from 
neonatal foreskin dermis were obtained from three sources. One 
culture was supplied by the Living Skin Bank (University Hospital, 
State University at Stony Brook, Stony Brook, NY); this fibroblast 
strain is referred to as LSB. Three cultures of foreskin fibroblasts, 
designated AG01437A, AG01519A, and AG01520A, were ob-
tained from the N ational Institute on Aging, Aging Cell Culture 
Repository, Coriell Institute for Medical Research (Camden, NJ) . 
One culture (A36) was obtained from the Department of Medicine 
(National Jewish Center for Immunology and Respiratory Medi-
cine, Denver, CO). All foreskin fibroblast strains were grown in 
minimal essential medium (No. 410-1100; Gibco, Gaithersburg, 
MD) containing 26 mM sodium bicarbonate; 30 mM HEPES (pH 
7.2); 10% heat-inactivated fetal bovine serum (HyClone Laborato-
ries, Logan, UT); 100 U /ml penicillin; and 100 Ilg/ml streptomy-
cin. Medium A, which was used in the experiments described 
below, is identical, except that it contains 0.1 % albumin in place of 
serum. 
Antibodies Mouse monoclonal antibodies specific for integrin 
subunits (X4 (P4G9) and (Xs (PI D6) were obtained from Telios Phar-
maceuticals (San Diego, CA). Additional monoclonal antibodies 
specific for integrin subunits were generously provided by the fol-
lowing investigators: anti-(X4 (B-5GI0) and anti-pt (A-lAS), M. 
Hemler, Dana-Farber Cancer Institute, Boston, MA; anti-(Xs 
(BllG2) and anti-PI (AIIB2), c. Damsky, University of California, 
San Francisco, CA; anti-(X4 (8F2) and anti-PI (4B4), C . Morimoto, 
Dana-Farber Cancer Institute, Boston, MA. Fluorescein-conjugated 
sheep anti-mouse IgG and fluorescein-conjugated goat anti-rat 
immunoglobulin (Ig) G were purchased from Cappel Jtesearch 
Products (Durham, NC). Control mouse ascites fluid came from 
Sigma Chemical Co. (St. Louis, MO). 
Fluorescence-Activated Cell Sorter Analysis of Integrin 
Expression The cell surface expression of integrins was analyzed 
by flow cytometry performed with a FACStar Plus cell sorter (Bec-
ton-Dickinson Immunocytometry Systems, San Jose, CA). Cul-
tures of fibroblasts were dispersed with 0.05% trypsin/0.02% eth-
ylenediaminetetraacetic acid (EDT A). After the trypsin was 
inactivated by the addition of a twofold excess of soy-bean trypsin 
inhibitor, the cells were washed twice in medium A, incubated for 
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10 min at 37°C to allow recovery, centrifuged, and then incubated 
with mouse or rat monoclonal antibody for 60 min at 4 ° C. These 
cells were washed three times with cold medium A, and then incu-
bated for 60 min at 4°C with a 1 : 150 dilution of fluorescein-conju-
gated sheep anti-mouse IgG or goat anti-rat IgG. Cells were 
washed three times with cold phosphate-buffered saline (PBS) and 
kept at 4 ° C in the dark until analyzed on the flow cytometer. 
Immunoprecipitation Fibroblast cell-surface proteins were 
biotinylated with the impermeant reagent NHS-LC-biotin (Pierce 
Chemical Co.). This technique was described previously [18]; it is a 
nonradioactive substitute for conventional iodination with 12Sl. 
Confluent fibroblast cultures in 175-cm2 flasks were washed three 
times with PBS containing 1 mM CaCl2 and 1 mM MgCl2 (PBS +) 
and then covered with 5 ml ofPBS+ containing 100 Jig/ml NHS-
LC-biotin (from a stock solution of 10 mg/ml in dimethylsulfox-
ide). The flasks were incubated for 30 min at 37°C and swirled 
occasionally. After biotinylation, the cell monolayer was washed 
three times with PBS + and immediately lysed. The lysis buffer 
contained 50 mM Tris(hydroxymethyl)aminomethane (Tris)-
HCI, (pH 7.5),150 mM NaCI, 1 mM CaCI2, 1 mM MgCI2, and 
0.3% CHAPS detergent (immunoprecipitation (IP) buffer [16]) and 
was supplemented with 1 mM N-ethylmaleimide, 1 mM phenyl-
methylsulfonyl fluoride, and 2llg/ml aprotinin to inhibit proteases. 
Cell monolayers were extracted by adding cold lysis buffer to the 
flask, approximately 1 ml/2 X 106 cells, and scraping the bottom of 
the flask with a rubber policeman. Cell lysates were collected and 
centrifuged in the cold at 10,000 X g for 10 min. The clarified 
lysates were stored at -90°C. 
Immunoprecipitations were performed using mouse monoclonal 
antibodies immobilized on agarose beads coupled with goat anti-
mouse IgG (No. A6531, Sigma Chemical Co.). Beads were incu-
bated for 3 h at room temperature with the appropriate antibody 
diluted in IP buffer, washed once with IP buffer, and then incubated 
overnight at 4 ° C with the biotinylated cell lysate. The beads were 
washed six times at 4°C with a buffer consisting of 50 mM Tris-
HCI (pH 7.5), 500 mM NaCI, 1 mM CaCI2, 1 mM MgCI2' 0.3% 
CHAPS, and 2 Ilg/ml aprotinin. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS - PAGE) sample buffer 
was added to the washed beads, and the tubes were boiled for 2 min. 
These samples were separated on a 7.5% polyacrylamide gel [19] 
and transferred to nitrocellulose [20]. The nitrocellulose blot was 
blocked with 3% albumin in Tris-buffered saline (TBS). The blot 
was then incubated at room temperature for 4 h in the same buffer 
containing streptavidin-alkaline phosphatase conjugate (Vector Lab-
oratories, Burlingame, CA) diluted 1: 3000. After incubation, the 
nitrocellulose was washed three times with TBS containing 0.1 % 
Tween 20. Finally, the alkaline phosphatase color reaction was 
performed as described previously [21]. 
Cell Attachment Assay The wells of a 96-well micro titer plate 
v.:ere coated overnight ~t ~ ° C with 50-Ill aliquots of matrix proteins 
dissolved 111 PBS contammg 0.02% sodium azide and then washed 
thre~ times with the same PBS. To block any remaining uncoated 
plastic, each well was treated at room temperature for 120 min with 
50 III of 20 mg/ml albumin in PBS. Before use in the assay, the 
wells were again washed three times with PBS. 
Cultures of fibroblasts were dispersed with 0.05% trypsin/0.02% 
EDTA. Trypsin was inactivated by the addition of modified Eagle's 
medium containing 10% fetal bovine serum. The cells were then 
washed twice in medium A and resuspended in medium A at a 
concentration of 180,000 cells/m!. 
Cell adhesion to matrix proteins was measured by adding 100 III 
of cell suspension to coated wells of the micro titer plate and incu-
bating the plate at 37"C for 30-60 min. At the end of the assay, 
unattached cells were removed by carefully washing three times 
With PBS. The remaining attached cells were fixed by treatment 
with 1 % glutaraldehyde (in distilled water) for 20 min at room 
temperature. The plate was then washed four times with water. The 
amount of cell attachment in each well was guantitated by using the 
bicinchoninic acid protein assay reagent [22J: 200 III of reagent was 
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Figure 1. FACS analysis of human foreskin fibroblasts . Fibroblast strains 
LSB (passage 8) and AG01519A (passage 8) were incubated with monoclo-
nal antibodies specific for a. (P4G9, 1 : 50), as (BIIG2, 1: 5), or PI (AIIB2, 
1 : 5). The III/shaded CIIrves represent the background fluorescence produced 
by secondary antibody alone. Similar background fluorescence was produced 
by a control mouse ascites fluid. For the LSB strain, the mean fluorescence 
intensity of a. was 15% of the mean fluorescence intensity of PI; for 
AG01519A, a. was 32% of PI' 
added to each well, and the color reaction was allowed to proceed 
overnight at room temperature. The absorbance at 562 nm (AS62) 
was then measured with a microtiter plate reader. Total attachment 
was expressed simply as AS62 ' Specific attachment was calculated by 
subtracting the cel l attachment to albumin from the cell attachment 
to intact matrix proteins or fibronectin fragments. 
In some experiments, a standard curve was used to convert the 
measured AS62 value into an actual cell number. The standard curve 
was constructed by preparing fibroblast cell suspensions over a range 
of concentrations, typically 10,000-180,000 cells/m!' Aliquots of 
100 J.ll of these cell suspensions were added to wells coated with 10 
J.lg/ml fibronectin, as described above, and the cells were allowed to 
attach for 60 min at 37 °C. All of the cells in each well were then 
fixed in place by adding 10 J.ll of an 11 % stock glutaraldehyde solu-
tion. After fixation for 20 min at room temperature, the plate was 
washed four times with water, and the protein assay reagent was 
used as described above. 
RESULTS 
Integrins a,PI and asfJl are cell-surface receptors for fibronectin. 
FACS analysis using monoclonal antibodies demonstrated that 
human foreskin fibroblasts express the integrin subunits of a" as, 
and PIon the cell surface. Figure 1 shows the results obtained from 
two different fibroblast strains. Comparable levels of a" as, and PI 
were also detected in two other fibroblast strains, AG01437A and 
AG01520A (data not shown) . FACS analysis with anothermonoclo-
nal antibody, B-5G 1 0, confirmed the presence of a, in the LSB 
strain (data not shown) . 
Immunoprecipitation experiments were undertaken next to ver-
ify the results of the FACS analysis. Fibroblast cell-surface proteins 
were precipitated with monoclonal antibodies specific for a" as, 
and PI (Fig 2). An antibody specific for a. precipitated two bands 
with the electrophoretic mobility characteristic of a, and PI . Two 
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Figure 2. Immunoprecipitation of a., as, and PI . Lysates of biotinylated 
LSB fibroblast monolayers were immunoprecipitated with control ascites 
anti-a. (P4G9), anti-as (P1 D6) , or anti-PI (A-lAS). Samples were separated 
by 5DS-PAGE under nonreducing conditions. 
other anti-a, antibodies, B-5G 1 0 and 8F2, produced identical re-
sults (data not sh.own): The anti-as monoclonal antibody precipi-
ta~ed two bands l.dentlfie~ by electrophoretic mobility as as and PI 
(Fig 2). The anti-PI antibody precipitated complexes apparently 
composed of a" as, and perhaps other a -subunits in association 
with PI (Fig 2). Exhaustive precipitation with anti-PI removed all of 
~he integrin precipitable ~ith anti-a, (data not shown), demonstrat-
mg that a,. IS present pnmarily as the complex a.fJ1 and not as a 
complex with another p-subunit. 
Cell-attachment assays were used to determine whether fibro-
blasts can i~deed at~ach to the IlICS fibronectin segment recognized 
by a,PI . Flbronect111 c?ntains two distinct cellular recognition re-
gIOns tha~ can be obtamed as separate fragments through limited 
proteolySlS of whole fibronectin. Normal human foreskin fibro-
blasts a~tached to a 120-kDa chymotryptic fragment, containing the 
RGO Site, and t.hey also attached to a 40-kDa fragment containing 
the IIICS domam (Fig 3). At a coating concentration of 40 J.lg/ml, 
the 40-~Da fibronectin fragment promoted cell adhesion nearly as 
well as mtact fibronectin at a coating concentration of 5 J.lg/m!. 
Furthermore, in repeated experiments, all of the fibroblast strains 
tested here demonstrated a similar attachment to the 40-kDa frag-
ment (data not shown). 
Subsequent assays revealed that inhibiting fibroblast attachment 
to the RGD site of fibronectin does not completely inhibit fibrobl ast 
attachment to fibronectin . Vitronectin and fibrinogen are integrin 
ligands similar to fibronectin, and all three contain RGD sites recog-
nized by integrins. However, the synthetic peptide GRGDSP only 
partially inhibited attachment to fibronectin, even thou gh it com-
pletely inhibited attachment to vitronectin and fibrinogen (Fig 4). 
In a series of experiments with different fibroblast strains, 1 mM 
GRGDSP inhibited adhesion to a coating of 5 J.lg/ ml fibronectin by 
26.4 ± 20.4% (n = 7). The closely related control peptide 
GRGESP did not inhibit attachment to any of the three substrates 
(data not shown). The 120-kDa fibronectin fragment is also an 
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Figure 3. Adhesion of fibroblasts to fibronectin fragments. Microtiter wells 
used for the assay were coated with the indicated concentrations of albumin 
(X), intact fibronectin (solid sqllare), or with the 40-kDa (triatlgle) or 120-
kDa (opetl square) fibronectin fragments. LSD fibroblasts were added and 
allowed to adhere for 60 min. The absorbance at 562 nm is proportional to 
the number of cells attached. Data shown are the means of triplicate points. 
incomplete inhibitor of attachment to fibronectin . At a concentra-
tion of 300 J.lg/ml, soluble 120-kDa fragment greatly inhibited 
adhesion to a substrate of the 120-kDa fragment, but it had compara-
tively little effect on adhesion to intact fibronectin (Fig 5). These 
results su ggested that fibroblast attachment to fibronectin did not 
depend entirely on attachment to the RGD site. 
Antibody-inhibition experiments were used to evaluate the role 
of ex..PI in fibroblast attachment to fibronectin. The data in Table I 
show that monoclonal antibodies against ex.. or PI individually inhib-
ited adhesion to the 40-kDa fragment of fibronectin and that to-
gether they were even more effective inhibitors. Anti-PI inhibited 
attachment to intact fibronectin and to the 40-kDa fragment. Anti-
ex.. , in contrast, had little effect on adhesion to intact fibronectin . As 
shown in Table II, however, combining the anti-ex.. antibody with 
the peptide GRGDSP substantially inhibited adhesion to intact fi-
bronectin. 
DISCUSSION 
In this review, we present evidence that normal human dermal 
fibroblasts express the integrin ex..PI and that this receptor facilitates 
fibroblast attachment to the IllCS domain of fibronectin. These 
observations show for the first time that ex..PI in normal fibroblasts 
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Figure 4. Inhibition of fibroblast attachment by GRGDSP peptide. Adhe-
sion substrates were prepared by coating with 50 Ilg/ml fibronectin (solid 
sqllare), 161lg/ml vitronectin (triallgle), or 8llg/ml fibrinogen (opetl square) . 
These concentratIOns were chosen to promote similar amounts of cel l adhe-
sion. A 36 fibroblasts were added in the presence of the indicated concentra-
tions ofGRGDSP peptide and allowed to attach for 60 min. Data shown are 
expressed relative to the number of cells attached to the appropriate substrate 
in the absence of peptide (11,000 on fibronectin, 10,000 on vitronectin, and 
8800 on fibrinogen) and are based on the means of quadruplicate points. 
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Figure 5. Inhibition of fibroblast attachment by 120-kDa fibronectin frag-
ment. Attachment substrates were coated with 10 Ilg/ml intact fibronectin 
(stippled bars) or with 10 Ilg/mI120-kDa fibronectin fragment (solid bars). 
LSD fibroblasts, mixed with the indicated concentrations of added 120-kDa 
fragment, were allowed to adhere for 30 min. Data shown are expressed 
relative to the number of cells attached in the absence of soluble fibronectin 
fragment and were calculated from the means of triplicate points. 
can function as a fibronectin receptor. FACS analysis and immuno-
precipitation with monoclonal antibodies demonstrated that human 
dermal fibroblasts express the ex.. -subunit on the cell surface, pri-
marily in association with the PI -subunit. Cell-attachment assays 
demonstrated that fibroblasts can attach to the 40-kDa fibronectin 
f~agment .containing the IllCS domain recognized by ex.~I' Adhe-
SIOn to tlllS fragment was inhibited by anti-ex.. antibody. Adhesion 
assays also suggested that ex..PI contributes to fibroblast attachment 
to intact fibronectin. This conclusion is supported indirectly by the 
observation that the RGD peptide or the 120-kDa fibronectin frag-
ment only partially inhibited attachment to intact fibronectin. More 
direct evidence comes from the observation that combining the 
~GD pepti.de with the anti-ex.. antibody produced stronger inhibi-
tion than either reagent alone. Both lines of evidence suggest that 
fibroblasts utilize more than one recognition sequence for binding 
to fibronectin. 
. These experiments investigated only two of the potential interac-
tions between ~br.oblasts and fibronectin: the binding of ex.~1 to 
IIICS and the bmdlllg of ex.sP! to RGD. However, other interactions 
may make important contributions to adhesion. Other integrins, 
such as ex.J31 and ex.vp!, can bind to fibronectin [5,10], and molecules 
that are not integrins, such as proteoglycans [7], can also mediate 
cellular interactions with fibronectin. Our results show that the 
40-kDa fibronectin fragment at relatively high concentrations can 
~romote fibroblast adhesion about as effectively as intact fibronec-
tm. Compared at equimolar concentrations, however, intact fibro-
nectin is a much better substrate, possibly because adhesion to full-
Table I . Inhibition of Fibroblast Adhesion by 
Antibodies Against ex.. and Pia 
% Control Adhesion' 
Fibroblast Strain Antibody Added FN FN 40 kDa 
LSD None 100 100 
Anti-a. 94 56' 
Anti-PI 59' 55' 
Anti-a. + anti-PI 54' 41 ' 
AG01519A None 100 100 
Anti-a. 90' 62' 
Anti-p. 33' 48' 
Anti-a, + anti-PI 29' 29' 
• Substrates were coated with a 5 JIg/ml fibrol1eetin or 40 JIg/m! fibronectin frag-
ment to promote SImilar amonnts of cell adhesion. LSB and AG01519A fibroblasts were 
incubated with the specified antibodies for 15 min before use in the attachment assay. 
Anti-a" P4G9 ascites fluid, was diluted 1: 50; anti-p .. AIIB2 culture supernatant, was 
diluted 1: 5. The number of cells attached after 60 min was measured. 
I Data shown are expressed relative to the number of cells attached to the appropriate 
substrate in the absence of antibody. 
, p < 0.05 by analysis of variance. 
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Table II. Inhibition of Fibroblast Adhesion to 





GRGDSP + anti-a4 
Number of Cells Attachedb % Control Adhesion 
8370 ± 470 100 
6020 ± 500 72 
7870 ± 310 94 
3420 ± 600' 41 
• Adhesion substrate was coated with 5 Jlg/rn1 libronectin. LSB fibrob lasts were 
incubated with the specified additions for 15 min before use in the attachment assay. 
The concentration of GRGDSP peptide was 1 mM; anti-a" P4G9 ascites fluid, was 
diluted 1 : 50. This assay measured the number of cells attached after 30 min. 
" Resulcs arc shown as mean ± so. 
, p < 0.001 by analysis of variance. 
length fibronectin can occur th~ough multiple interactions. at sev-
eral different sites. These multiple mteractions may explam why 
blocking the function of both a4PI and asP.I is still not sufficient to 
completely inhibit attachment to fibronectm (Tables I and II). 
Our results demonstrate that a 4PI is functionally expressed by 
cultured dermal fibroblasts. However, a4PI has not yet been identi-
fied in fibroblasts in normal skin [23,24). There are several possible 
explanations for why i.t is present it! vitro bu.t appears to be absent ill 
vivo. First, the expression of a 4PI could be mduced by cell culture. 
The expression of functiona l asPl by keratinocytes is markedly 
increased after 2-4 d in culture [25) . Second, the apparent absence 
of a4PI in normal skin could reflect a low, but still potentially 
significant, level of expression. More sensitive detection methods 
should permit a more certain conclusion. Third, a 4PI may not be 
present in normal skin, but it may be specifically i~duced by cyto-
kines during the process of cutaneous wound repair or dunng the 
development of inflammatory skil~ disease. <?yt~kines, or in~amma­
tory mediators, can regulate mtegnn expressIOn m human skm fibro-
blasts [26) and in other cell types. 
Fibroblast interactions with fibronectin are especially relevant 
during wound repair. In addition to serving as a chemotactic factor 
and as an opsonin, fibronectin forms part of the provisional w?und 
matrix that supports the migrating epithelial sheet and that IS mfil-
trated by macrophages, endothelial cells, and fibroblasts [27). Flbro-
nectin promotes keratinocyte migration, and the fibronectin recep-
tor asPl must be activated before keratinocyte migration occurs 
[28). The integrins responsible for the migration of normal fibro-
blasts have not been identified. It is possible that a4PI is involved m 
the process of fibroblast locomotion. There is recent evidence that 
the cytoplasmic tail of a 4 enhances the migration of transfected 
rhabdomyosarcoma cells [29]. 
The extent to which a4PI contributes to fibroblast adhesion, or to 
migration, may depend on the fibronectin isoforms in the 
surrounding matrix. Integrin a 4PI binds primarily to a span of fibro-
nectin that is not found in all isoforms but rather is expressed m a 
cell-type-specific manner [30). The level of fibronectin mRNA 
present in wounds is much higher than that found in normal adu~t 
rat skin, and the mRNA in wounds shows a pattern of splicing that IS 
different from that found in normal adult skin but is similar to that 
found in the early embryo [31] . The fibronectin IIICS domain actu-
ally consists of two segments that can be independently processed 
during mRNA splicing. One segment contains the CS-l sit.e; the 
other segment contains the CS-5 site. Although a4PI can bmd to 
either site, it has a much higher affinity for CS-1 [13). ExpreSSIOn of 
fibronectin mRNA that includes CS-1 has been observed durmg 
cutaneous wound healing (L. Van De Water, personal communica-
tion). Thus, during wound repair, or embryogenesis, the ability of a 
fibroblast to bind to fibronectin through a 4PI could be regulated by 
changing the fibronectin isoforms deposited in the matrix. This 
method of regulation, however, is probably not absolute. It was 
recently discovered in melanoma cells that a 4PI recognizes a third 
site of fibronectin present in all isoforms [32]. 
Thus far we have only addressed the function of a~1 as a fibronec-
tin receptor, but it should be mentioned that a~1 actually has at 
least three distinct adhesion functions [33]. In addition to mediating 
cell attachment to the IIICS domain of fibronectin, it also partici-
INTEGRIN ON HUMAN DERMAL FIBROBLASTS 327 
pates in heterotypic and homotypic cell- cell adhesion. Leukocyte 
integrin a4PI binds to VCAM-1 on the surface of activated endothe-
lial cells [3 ,14) and to unknown ligands during leukocyte aggrega-
tion [34,35]. Cell- cell interactions between a 4PI and VCAM-1 also 
appear to be important for myogenesis [36] . Our observations indi-
cate that a 4PI is more widely distributed than first thought, and they 
prompt the question of whether a4PI can serve in fibroblasts some of 
the same cell- cell adhesive functions that it serves in other cell 
types . 
We tlratlk Ol/r colleag'les, Drs. Damsky, Hemler, al,d Morimoto, Jar generol/sly 
providitlg atltibodies. The expert tecl",ical assistatlceoJCeorgia Ede, ROtlg Chen, atld 
James Simotle is gratefl/Ily acktlOwledged. 
T!.is research was sllpported itl part by gro tlt AC1 0143-09 from the Nalional 
[tlslill/le Otl Aging atld by fimds from the Siale Utliversity oJNew York. 
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